The changing role of beta-blocker therapy in patients with cirrhosis

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

MELD: the holy grail of organ allocation?

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Volume 59, Issue 6, Pages (December 2013)

MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis Wichit Srikureja,

Thrombocytopenia With Abnormal Liver Function Tests

Volume 68, Issue 5, Pages (May 2018)

Primary prevention of variceal haemorrhage: A pharmacological approach

Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Volume 61, Issue 6, Pages (December 2014)

The impact of hepatitis E in the liver transplant setting

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Non-invasive diagnosis of non-alcoholic fatty liver disease

Immigration and viral hepatitis

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

European Association for the Study of the Liver Journal of Hepatology

Volume 61, Issue 5, Pages (November 2014)

Phillip S. Ge, MD, Bruce A. Runyon, MD

Mesenchymal stromal cell therapy for liver diseases

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Autoimmune hepatitis: A life-long disease

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

European Association for the Study of the Liver Journal of Hepatology

Hepatitis C core protein – The “core” of immune deception?

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Cirrhosis and other liver disease in cystic fibrosis

Volume 62, Issue 3, Pages (March 2015)

Genomic risk of hepatitis C-related hepatocellular carcinoma

Volume 59, Issue 3, Pages (September 2013)

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

S. Tamir Rashid, Graeme J.M. Alexander Journal of Hepatology

Volume 57, Issue 5, Pages (November 2012)

Volume 53, Issue 6, Pages (December 2010)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Paul C. Adams, James C. Barton Journal of Hepatology

Immigration and viral hepatitis

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

Volume 64, Issue 6, Pages (June 2016)

Changes in the 24-h plasma cortisol rhythm in patients with cirrhosis

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Thrombocytopenia With Abnormal Liver Function Tests

New trials and results in systemic treatment of HCC

Liver transplantation in children

Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi

Volume 60, Issue 6, Pages (June 2014)

Pathogenesis of cholestatic hepatitis C

Volume 50, Issue 1, Pages 4-6 (January 2009)

MELD: the holy grail of organ allocation?

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Volume 60, Issue 6, Pages (June 2014)

Presentation transcript:

The changing role of beta-blocker therapy in patients with cirrhosis Phillip S. Ge, Bruce A. Runyon Journal of Hepatology Volume 60, Issue 3, Pages 643-653 (March 2014) DOI: 10.1016/j.jhep.2013.09.016 Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 1 The differential effect of beta-blockers in cirrhosis. Modified with permission from: Krag A, Wiest R, Albillos A, Gluud LL. The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease. Gut 2012;61:967–969. Copyright © 2012 BMJ Group. Journal of Hepatology 2014 60, 643-653DOI: (10.1016/j.jhep.2013.09.016) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Algorithmic approach for beta-adrenergic antagonists in patients with cirrhosis. BP, blood pressure; EGD, esophagogastroduodenoscopy. Journal of Hepatology 2014 60, 643-653DOI: (10.1016/j.jhep.2013.09.016) Copyright © 2013 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2014 60, 643-653DOI: (10. 1016/j. jhep. 2013. 09 Copyright © 2013 European Association for the Study of the Liver Terms and Conditions